mci 9038 has been researched along with Atheroma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, Y | 1 |
| Aguilera, TA; Baik, FM; Baird, SM; Crisp, JL; Friedman, B; Jiang, T; Nguyen, QT; Olson, ES; Tsien, RY; Tsimikas, S; Whitney, MA | 1 |
1 review(s) available for mci 9038 and Atheroma
| Article | Year |
|---|---|
[Concept, pathophysiology and treatment for branch atheromatous disease].
Topics: Antipyrine; Arginine; Cerebral Infarction; Cilostazol; Clopidogrel; Contraindications; Drug Therapy, Combination; Edaravone; Humans; Magnetic Resonance Imaging; Pipecolic Acids; Plaque, Atherosclerotic; Platelet Aggregation Inhibitors; Sulfonamides; Tetrazoles; Ticlopidine; Tissue Plasminogen Activator | 2014 |
1 other study(ies) available for mci 9038 and Atheroma
| Article | Year |
|---|---|
In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
Topics: Amino Acid Sequence; Animals; Antithrombins; Aorta; Arginine; Cell-Penetrating Peptides; Fluorescent Dyes; Hirudins; Histocytochemistry; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; Pipecolic Acids; Plaque, Atherosclerotic; Receptor, PAR-1; Recombinant Proteins; Sulfonamides; Thrombin | 2012 |